Literature DB >> 28781788

Inhibition of PC3 human prostate cancer cell proliferation, invasion and migration by eicosapentaenoic acid and docosahexaenoic acid.

Keiichi Oono1, Katsuya Takahashi1, Saeka Sukehara1, Hirohito Kurosawa1, Tomio Matsumura2,3, Shun'Ichiro Taniguchi4, Shoichiro Ohta1.   

Abstract

The n-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), found in fish oil, exert a number of beneficial effects, and they are used in the treatment of hyperlipidemia. In recent years, EPA and DHA have been found to affect cancer cell proliferation. In the present study, PC3 cells, which are androgen-independent prostate cancer cells that resemble castration-resistant prostate cancer cells, were used to investigate a possible novel treatment for castration-resistant prostate cancer. The PC3 cells were cultured and incubated with various concentrations of EPA or DHA. Cancer proliferation was confirmed by trypan blue microscopy. Invasion and migration assays were used in the upper chamber in PC3 cells, and serum-free medium and various concentrations of EPA or DHA were placed in the lower chamber in serum-containing medium. EPA and DHA decreased PC3 cell proliferation, invasion and migration. The effect of EPA on PC3 cells was dose-dependent and significant differences were observed at concentrations of 100 and 200 µg/ml. The effect of DHA on PC3 cells was similar to that of EPA. In the migration assay, EPA exerted almost no effects at 25 µg/ml, but migration was reduced at 50 µg/ml. Similar to EPA, DHA exerted almost no effects at 25 µg/ml, but further reduction was observed at the 50 µg/ml concentration. In the invasion assay, EPA at 25 µg/ml was not significantly different from the control, but suppressed invasion at 50 µg/ml. DHA decreased invasion compared with the control at 25 µg/ml, whereas invasion was significantly reduced at a DHA concentration of 50 µg/ml. In conclusion, it was demonstrated that EPA and DHA were effective in decreasing the proliferation, invasion and migration of prostate PC3 cancer cells. However, the detailed underlying mechanisms have not yet been fully elucidated.

Entities:  

Keywords:  PC3; docosahexaenoic acid; eicosapentaenoic acid; invasion assay; prostate cancer

Year:  2017        PMID: 28781788      PMCID: PMC5532687          DOI: 10.3892/mco.2017.1287

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  18 in total

Review 1.  Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review.

Authors:  W S Harris
Journal:  J Lipid Res       Date:  1989-06       Impact factor: 5.922

Review 2.  N-3 fatty acids, cancer and cachexia: a systematic review of the literature.

Authors:  Ramón Colomer; José M Moreno-Nogueira; Pedro P García-Luna; Pilar García-Peris; Abelardo García-de-Lorenzo; Antonio Zarazaga; Luis Quecedo; Juan del Llano; Luis Usán; César Casimiro
Journal:  Br J Nutr       Date:  2007-05       Impact factor: 3.718

3.  Eicosapentaenoic acid (EPA) induced apoptosis in HepG2 cells through ROS-Ca(2+)-JNK mitochondrial pathways.

Authors:  Yuanyuan Zhang; Lirong Han; Wentao Qi; Dai Cheng; Xiaolei Ma; Lihua Hou; Xiaohong Cao; Chunling Wang
Journal:  Biochem Biophys Res Commun       Date:  2014-12-18       Impact factor: 3.575

4.  Effects of highly purified ethyl all-cis-5,8,11,14,17-icosapentaenoate (EPA-E) on rabbit platelets.

Authors:  M Sato; Y Katsuki; K Fukuhara; H Kawano; M Mizota; Y Hamada; Y Kunihiro
Journal:  Biol Pharm Bull       Date:  1993-04       Impact factor: 2.233

5.  [Effects of ethyl all-cis-5,8,11,14,17-icosapentaenoate (EPA-E) on elasticity and endothelium-dependent relaxation of the aorta in high cholesterol diet-fed rabbits].

Authors:  M Sato; Y Katsuki; H Kanehiro; H Kawano; M Mizota
Journal:  Nihon Yakurigaku Zasshi       Date:  1994-07

6.  Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma.

Authors:  Chun-Fung Chan; Tai-On Yau; Dong-Yan Jin; Chun-Ming Wong; Sheung-Tat Fan; Irene Oi-Lin Ng
Journal:  Clin Cancer Res       Date:  2004-06-15       Impact factor: 12.531

7.  The role of PI3K/AKT-related PIP5K1α and the discovery of its selective inhibitor for treatment of advanced prostate cancer.

Authors:  Julius Semenas; Andreas Hedblom; Regina R Miftakhova; Martuza Sarwar; Rikard Larsson; Liliya Shcherbina; Martin E Johansson; Pirkko Härkönen; Olov Sterner; Jenny L Persson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-28       Impact factor: 11.205

8.  Marine- and plant-derived ω-3 fatty acids differentially regulate prostate cancer cell proliferation.

Authors:  Pinar O Eser; John P Vanden Heuvel; John Araujo; Jerry T Thompson
Journal:  Mol Clin Oncol       Date:  2013-02-15

9.  Effects of eicosapentaenoic acid and docosahexaenoic acid on prostate cancer cell migration and invasion induced by tumor-associated macrophages.

Authors:  Cheng-Chung Li; Yu-Chen Hou; Chiu-Li Yeh; Sung-Ling Yeh
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

10.  DHA inhibits protein degradation more efficiently than EPA by regulating the PPARγ/NFκB pathway in C2C12 myotubes.

Authors:  Yue Wang; Qiao-wei Lin; Pei-pei Zheng; Jian-song Zhang; Fei-ruo Huang
Journal:  Biomed Res Int       Date:  2013-07-28       Impact factor: 3.411

View more
  10 in total

1.  SQSTM1/p62 is involved in docosahexaenoic acid-induced cellular autophagy in glioblastoma cell lines.

Authors:  Xuefeng Tan; Linqing Zou; Jianbing Qin; Donglin Xia; Youlang Zhou; Guohua Jin; Zhuang Jiang; Haoming Li
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-08-19       Impact factor: 2.416

2.  Docosahexaenoic acid (DHA), an omega-3 fatty acid, inhibits tumor growth and metastatic potential of ovarian cancer.

Authors:  Lindsay West; Yajie Yin; Stuart R Pierce; Ziwei Fang; Yali Fan; Wenchuan Sun; Katherine Tucker; Allison Staley; Chunxiao Zhou; Victoria Bae-Jump
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

3.  Differential Transcriptomic Profiles Following Stimulation with Lipopolysaccharide in Intestinal Organoids from Dogs with Inflammatory Bowel Disease and Intestinal Mast Cell Tumor.

Authors:  Dipak Kumar Sahoo; Dana C Borcherding; Lawrance Chandra; Albert E Jergens; Todd Atherly; Agnes Bourgois-Mochel; N Matthew Ellinwood; Elizabeth Snella; Andrew J Severin; Martin Martin; Karin Allenspach; Jonathan P Mochel
Journal:  Cancers (Basel)       Date:  2022-07-20       Impact factor: 6.575

Review 4.  Roles of endogenous ether lipids and associated PUFAs in the regulation of ion channels and their relevance for disease.

Authors:  Delphine Fontaine; Sandy Figiel; Romain Félix; Sana Kouba; Gaëlle Fromont; Karine Mahéo; Marie Potier-Cartereau; Aurélie Chantôme; Christophe Vandier
Journal:  J Lipid Res       Date:  2020-04-07       Impact factor: 5.922

5.  Docosahexaenoic acid inhibits vascular smooth muscle cell migration and proliferation by decreasing microRNA‑155 expression levels.

Authors:  Xiaoliang Yin; Chunbo Xu; Qiyang Xu; Dehai Lang
Journal:  Mol Med Rep       Date:  2020-08-03       Impact factor: 2.952

6.  Melatonin and Docosahexaenoic Acid Decrease Proliferation of PNT1A Prostate Benign Cells via Modulation of Mitochondrial Bioenergetics and ROS Production.

Authors:  Guilherme H Tamarindo; Daniele L Ribeiro; Marina G Gobbo; Luiz H A Guerra; Paula Rahal; Sebastião R Taboga; Fernanda R Gadelha; Rejane M Góes
Journal:  Oxid Med Cell Longev       Date:  2019-01-09       Impact factor: 6.543

7.  Physiological Role of Glutamate Dehydrogenase in Cancer Cells.

Authors:  Rafael Moreno-Sánchez; Álvaro Marín-Hernández; Juan C Gallardo-Pérez; Silvia C Pacheco-Velázquez; Diana X Robledo-Cadena; Joaquín Alberto Padilla-Flores; Emma Saavedra; Sara Rodríguez-Enríquez
Journal:  Front Oncol       Date:  2020-04-09       Impact factor: 6.244

8.  Contribution of Pyk2 pathway and reactive oxygen species (ROS) to the anti-cancer effects of eicosapentaenoic acid (EPA) in PC3 prostate cancer cells.

Authors:  Keiichi Oono; Kazuo Ohtake; Chie Watanabe; Sachiko Shiba; Takashi Sekiya; Keizo Kasono
Journal:  Lipids Health Dis       Date:  2020-01-31       Impact factor: 3.876

Review 9.  The Crosstalk between Prostate Cancer and Microbiota Inflammation: Nutraceutical Products Are Useful to Balance This Interplay?

Authors:  Felice Crocetto; Mariarosaria Boccellino; Biagio Barone; Erika Di Zazzo; Antonella Sciarra; Giovanni Galasso; Giuliana Settembre; Lucio Quagliuolo; Ciro Imbimbo; Silvia Boffo; Italo Francesco Angelillo; Marina Di Domenico
Journal:  Nutrients       Date:  2020-08-31       Impact factor: 5.717

10.  The Effect of Fatty Acids on Ciprofloxacin Cytotoxic Activity in Prostate Cancer Cell Lines-Does Lipid Component Enhance Anticancer Ciprofloxacin Potential?

Authors:  Alicja Chrzanowska; Wioletta Olejarz; Grażyna Kubiak-Tomaszewska; Andrzej K Ciechanowicz; Marta Struga
Journal:  Cancers (Basel)       Date:  2022-01-14       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.